Thailand,
July 2012
The report offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into a country already leading the way in Southeast Asia and with the potential to grow further.
With a burgeoning middle class and aging population the demand for healthcare is stronger than ever in Thailand. As the country is the number one destination for medical tourism in the world, a member of ASEAN and of the forthcoming ASEAN Economic Community, greater understanding of the Thai pharma and healthcare sectors is vital for all stakeholders.
It features interviews with senior executives from major companies in Thailand and leaders of some of the country’s most important institutions, updated facts and figures on Thailand’s healthcare and pharma sectors, and feature stories.
The report offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into a country already leading the way in Southeast Asia and with the potential to grow further.
With a burgeoning middle class and aging population the demand for healthcare is stronger than ever in Thailand. As the country is the number one destination for medical tourism in the world, a member of ASEAN and of the forthcoming ASEAN Economic Community, greater understanding of the Thai pharma and healthcare sectors is vital for all stakeholders.
It features interviews with senior executives from major companies in Thailand and leaders of some of the country’s most important institutions, updated facts and figures on Thailand’s healthcare and pharma sectors, and feature stories.
